-1.07%
Today
Loading 1D prices…
Company profile
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
VANCOUVER, British Columbia, Canada, United States
Employees
89
Fiscal year end
1231
CIK
1723464
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| VERUVeru Inc. Common Stock | $41.6M | $0.00 | — | -$1.55 | -2.40% | Buy |
| CELUCelularity Inc. Class A Common Stock | $40.8M | $26.6M | -345.45% | -$3.59 | -1.74% | Buy |
| EDSAEdesa Biotech Inc. Common Shares | $40.8M | $0.00 | — | -$1.27 | -9.23% | Buy |
| ATNMActinium Pharmaceuticals Inc. (Delaware) Common Stock | $44M | $90K | -37652.22% | -$1.09 | +6.87% | Buy |
| NSRXNasus Pharma Ltd. Ordinary Shares | $39.9M | $1.2B | -0.47% | -$0.72 | +1.64% | Buy |